Today a meeting was held between representatives of the Institute of Health for Well-being (Insabi) and the United Nations Office of Project Services (Unops), together with directors of the Mexican Association of Pharmaceutical Research Industries (AMIIF), the Mexican Association of Pharmaceutical Laboratories (Amelaf), the National Association of Drug Manufacturers (Anafam), the National Chamber of the Pharmaceutical Industry (Canifarma) and the Mexican Association of Innovative Medical Device Industries (AMID).
During the meeting, the common commitment was strengthened to implement specific actions that allow a favorable continuation of the supply of medicines and healing materials to serve the Mexican population.
As part of the open communication that Insabi and Unops maintain with the associations from the beginning of the purchase process, the meeting addressed issues related to the progress in deliveries corresponding to the 2021 purchase, in addition to the results of the tables of work and the key points that will be strengthened in the purchase bases for 2022.
Since the beginning of this year, technical working groups have been permanently established with representatives of the pharmaceutical industry who participate in the consolidated purchase, in order to align operational aspects and continue to facilitate supply. These workshops are primarily focused on delivery logistics, contract management, and quality assurance.
Representatives of the pharmaceutical industry recognized that these spaces for dialogue are essential to continue contributing together so that millions of Mexican men and women have their medicines in a timely manner.